Menu

• Ask a Health Expert about PERFORMANCE STATUS DECREASED
• Post Your Side Effect related to PERFORMANCE STATUS DECREASED
• PERFORMANCE STATUS DECREASED and FDA Warnings
• PERFORMANCE STATUS DECREASED in Patients Wiki
• Report PERFORMANCE STATUS DECREASED in Drug Side Effect Survey

PERFORMANCE STATUS DECREASED side effect

What is PERFORMANCE STATUS DECREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Mirtazapine Side Effects Report #5678719-4
Consumer or non-health professional from UNITED STATES reported MIRTAZAPINE problem on Mar 24, 2008. Female patient, 63 years of age, weighting 85.00 lb, was diagnosed with anorexia, fatigue and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . MIRTAZAPINE dosage: 15 MG 1 DAILY PO. During the same period patient was treated with LITHIUM, CLONAZEPAM, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.

Chantix Side Effects Report #5635574-6
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 12, 2008. Male patient, weighting 69.00 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: performance status decreased, somnolence, . CHANTIX dosage: unknown. During the same period patient was treated with CARBAMAZEPINE, LORAZEPAM, ATENOLOL, NEURONTIN, CYMBALTA, HYDROCHLOROTHIAZIDE. Patient recovered.

Navelbine Side Effects Report #5472281-7
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure, . NAVELBINE dosage: 25 MG/M2 IV. Patient died.

Navelbine Side Effects Report #5472282-9
NAVELBINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 72 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: performance status decreased, respiratory failure, . NAVELBINE dosage: 25 MG/M2 IV. Patient died.


Docetaxel Side Effects Report #5709030-0
Health Professional from UNITED STATES reported DOCETAXEL problem on Apr 16, 2008. Female patient, weighting 155.0 lb, was diagnosed with pancreatic carcinoma metastatic and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . DOCETAXEL dosage: unknown. During the same period patient was treated with GEMCITABINE, CAPECITABINE. Patient died on 04/12/2008.

Cetuximab Side Effects Report #5334492-0
CETUXIMAB problem was reported by a Health Professional from GERMANY on May 21, 2007. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: performance status decreased, . CETUXIMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.

Eskalith Side Effects Report #5302233-9
Consumer or non-health professional from UNITED STATES reported ESKALITH problem on Apr 13, 2006. Female patient, 20 years of age, was treated with ESKALITH. After drug was administered, patient experienced the following problems/side effects: performance status decreased, tremor, . ESKALITH dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, LITHIUM CARBONATE, KLONOPIN. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5652919-1
MYLOTARG problem was reported by a Physician from JAPAN on Feb 26, 2008. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, performance status decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with CEFZON, MEROPEN, DIFLUCAN, MAXIPIME. Patient was hospitalized. Patient recovered.

Chantix Side Effects Report #5620863-1
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Jan 28, 2008. Female patient, weighting 149.9 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: dizziness, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with VITAMIN B, FISH OIL. Patient recovered.


Mylotarg Side Effects Report #5581454-4
MYLOTARG problem was reported by a Physician from JAPAN on Dec 25, 2007. Female patient, weighting 112.4 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: neutrophil count decreased, performance status decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with CEFZON, MEROPEN, DIFLUCAN, MAXIPIME. Patient recovered.

Sutent Side Effects Report #5514646-0
Consumer or non-health professional from ARGENTINA reported SUTENT problem on Nov 01, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.

Coreg Side Effects Report #5519902-8
COREG CR problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient was treated with COREG CR. After drug was administered, patient experienced the following problems/side effects: lethargy, performance status decreased, . COREG CR dosage: unknown. During the same period patient was treated with CELEBREX, FOSAMAX, EVISTA, IMDUR, POLYPHARMACY. Patient recovered.

Avandamet Side Effects Report #5520902-2
Consumer or non-health professional from GERMANY reported AVANDAMET problem on Nov 14, 2007. Male patient, 70 years of age, was treated with AVANDAMET. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . AVANDAMET dosage: 1002MG TWICE PER DAY. During the same period patient was treated with METFORMIN HYDROCHLORIDE. Patient recovered.

Sutent Side Effects Report #5525826-2
SUTENT problem was reported by a Consumer or non-health professional from ARGENTINA on Nov 14, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL. Patient recovered.


Mylotarg Side Effects Report #5493374-4
Physician from JAPAN reported MYLOTARG problem on Oct 11, 2007. Female patient, weighting 85.98 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, performance status decreased, platelet count decreased, pleural effusion, sepsis, weight increased, . MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, LEVOFLOXACIN, FLAGYL, VANCOMYCIN, ITRIZOLE. Patient died on 06/22/2007.

Sutent Side Effects Report #5502371-1
SUTENT problem was reported by a Consumer or non-health professional from ARGENTINA on Oct 18, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.

Busulfan Side Effects Report #5447576-3
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Aug 22, 2007. Male patient, child 10 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, performance status decreased, venoocclusive liver disease, . BUSULFAN dosage: 0.8 MG/KG;1X;. Patient died on 05/27/2007.

Sutent Side Effects Report #5468783-X
SUTENT problem was reported by a Consumer or non-health professional from ARGENTINA on Sept 17, 2007. Male patient, weighting 154.3 lb, was diagnosed with renal cancer metastatic and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: anaemia, performance status decreased, . SUTENT dosage: unknown. During the same period patient was treated with AMINO ACIDS, MEGESTROL ACETATE. Patient recovered.

Navelbine Side Effects Report #5472283-0
Consumer or non-health professional from UNITED STATES reported NAVELBINE problem on Sept 04, 2007. Female patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: infection, performance status decreased, . NAVELBINE dosage: 25 MG/M2 IV. During the same period patient was treated with DOCETAXEL. Patient died.


Temodal Side Effects Report #5442991-6
TEMODAL problem was reported by a Physician from UNITED KINGDOM on Aug 24, 2007. Female patient, 78 years of age, weighting 165.1 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, performance status decreased, pharyngolaryngeal pain, . TEMODAL dosage: 15 MG; QD; PO. During the same period patient was treated with PHENYTOIN, DEXAMETHASONE, DOMPERIDONE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5766945-5
Health Professional from AUSTRIA reported DOXORUBICIN problem on June 04, 2008. Female patient, 66 years of age, weighting 160.5 lb, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: hypokalaemia, performance status decreased, . DOXORUBICIN dosage: unknown. During the same period patient was treated with HYDAL, SPIROBENE, THYREX, NAPROXEN, CALCIUM, POTASSIUM CHLORIDE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5729866-X
REVLIMID problem was reported by a Physician from UNITED STATES on Apr 22, 2008. Female patient, 66 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, performance status decreased, . REVLIMID dosage: 10 MG, QD X21 DAYS, ORAL. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5361354-5
Physician from JAPAN reported TEMODAL problem on June 08, 2007. Female patient, 29 years of age, weighting 97.00 lb, was diagnosed with oligodendroglioma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: lymphocyte count decreased, performance status decreased, pneumonia aspiration, sepsis, . TEMODAL dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ALEVIATIN, UNASYN, FLUMARIN, EXCEGRAN, TAKEPRON QD, MAGENESIUM OXIDE, NASEA OD, BIOFERMIN R. Patient died on 04/02/2007.

Lapatinib Side Effects Report #5313844-9
LAPATINIB problem was reported by a Physician from SWITZERLAND on Apr 25, 2007. Female patient, 60 years of age, weighting 132.3 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, performance status decreased, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Taxotere Side Effects Report #5295730-6
Health Professional from UNITED STATES reported TAXOTERE problem on Apr 10, 2007. Male patient, 38 years of age, was diagnosed with pharyngeal cancer metastatic and was treated with TAXOTERE. After drug was administered, patient experienced the following problems/side effects: disease progression, performance status decreased, . TAXOTERE dosage: 64MG, IV. During the same period patient was treated with VELCADE. Patient died on 10/20/2005.

Capecitabine Side Effects Report #5255382-8
CAPECITABINE problem was reported by a Physician from UNITED STATES on Feb 27, 2007. Male patient, 58 years of age, weighting 198.4 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: paronychia, performance status decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, LASIX, SPIROLACTONE, PROPRANOLOL, LACTULOSE, MG OXIDE. Patient was hospitalized. Patient recovered.

Capecitabine Side Effects Report #5266323-1
Physician from UNITED STATES reported CAPECITABINE problem on Mar 06, 2007. Male patient, 58 years of age, weighting 198.4 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: paronychia, performance status decreased, . CAPECITABINE dosage: unknown. During the same period patient was treated with CETUXIMAB, OXALIPLATIN, LASIX, SPIROLACTONE, PROPRANOLOL, LACTULOSE, MG OXIDE. Patient was hospitalized. Patient recovered.

Requip Side Effects Report #5654788-2
REQUIP problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2007. Male patient, 21 years of age, was diagnosed with restless legs syndrome and was treated with REQUIP. After drug was administered, patient experienced the following problems/side effects: disability, feeling abnormal, performance status decreased, . REQUIP dosage: unknown. Patient recovered.

Mylotarg Side Effects Report #5664832-4
Physician from JAPAN reported MYLOTARG problem on Mar 07, 2008. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, performance status decreased, platelet count decreased, subdural haematoma, . MYLOTARG dosage: unknown. During the same period patient was treated with MEILAX, FAMOTIDINE, BAKTAR, CARBENIN, BIKLIN. Patient died on 06/11/2007.

Chantix Side Effects Report #5669946-0
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 05, 2008. Male patient, weighting 197.1 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: motor dysfunction, mutism, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient recovered.

Chantix Side Effects Report #5676250-3
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Mar 10, 2008. Male patient, 44 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with STRATTERA, METHYLPHENIDATE, REQUIP. Patient recovered.

Chantix Side Effects Report #5685393-X
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 18, 2008. Female patient, weighting 149.9 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: asthenia, muscular weakness, performance status decreased, . CHANTIX dosage: unknown. Patient recovered.

Singulair Side Effects Report #5690680-5
Consumer or non-health professional from UNITED STATES reported SINGULAIR problem on Mar 31, 2008. Female patient, 41 years of age, weighting 220.0 lb, was diagnosed with seasonal allergy and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: depression, impaired work ability, performance status decreased, suicidal ideation, . SINGULAIR dosage: 10 MG DAILY PO. Patient recovered.

Advair Side Effects Report #5622644-1
ADVAIR DISKUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Male patient, 24 years of age, weighting 180.0 lb, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: depression, feeling abnormal, performance status decreased, vision blurred, . ADVAIR DISKUS dosage: unknown. Patient recovered.

Sandostatin Side Effects Report #5631796-9
Physician from BELGIUM reported SANDOSTATIN LAR problem on Feb 12, 2008. Male patient, 64 years of age, weighting 116.8 lb, was diagnosed with carcinoid tumour and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, fatigue, performance status decreased, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5636342-1
SANDOSTATIN LAR problem was reported by a Physician from BELGIUM on Feb 18, 2008. Male patient, 64 years of age, weighting 116.8 lb, was diagnosed with carcinoid tumour and was treated with SANDOSTATIN LAR. After drug was administered, patient experienced the following problems/side effects: diarrhoea, fatigue, performance status decreased, . SANDOSTATIN LAR dosage: unknown. Patient was hospitalized. Patient died on 02/17/2008.

Revlimid Side Effects Report #5613625-2
Physician from UNITED STATES reported REVLIMID problem on Jan 21, 2008. Female patient, 75 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: constipation, fatigue, performance status decreased, weight decreased, . REVLIMID dosage: 15 MG, QD, ORAL; 25 MG, QD, ORAL. Patient died on 08/27/2007.

Mylotarg Side Effects Report #5570727-7
MYLOTARG problem was reported by a Physician from JAPAN on Dec 12, 2007. Female patient, weighting 101.4 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: anaemia, neutrophil count decreased, performance status decreased, platelet count decreased, subdural haematoma, . MYLOTARG dosage: unknown. During the same period patient was treated with MEILAX, GASTER, BAKTAR, CARBENIN, BIKLIN. Patient died on 06/05/2007.

Chantix Side Effects Report #5473836-6
Consumer or non-health professional from UNITED STATES reported CHANTIX problem on Sept 19, 2007. Female patient, weighting 145.1 lb, was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: dizziness, nausea, performance status decreased, stomach discomfort, . CHANTIX dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient recovered.

Wellbutrin Side Effects Report #5430826-7
WELLBUTRIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2006. Female patient was diagnosed with depression and was treated with WELLBUTRIN. After drug was administered, patient experienced the following problems/side effects: depression, pain, performance status decreased, therapeutic response unexpected, . WELLBUTRIN dosage: 300MG PER DAY. Patient recovered.

Alimta Side Effects Report #5774864-3
Physician from JAPAN reported ALIMTA problem on June 04, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment, . ALIMTA dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Vinorelbine Side Effects Report #5732775-3
VINORELBINE problem was reported by a Health Professional from UNITED STATES on May 07, 2008. Female patient, weighting 100.0 lb, was diagnosed with breast cancer metastatic and was treated with VINORELBINE. After drug was administered, patient experienced the following problems/side effects: diarrhoea, disease progression, performance status decreased, . VINORELBINE dosage: 25 MG/M2 D 1,8,15 Q 28 D IV. During the same period patient was treated with LAPATINIB. Patient died on 04/08/2008.

Alimta Side Effects Report #5743874-4
Physician from JAPAN reported ALIMTA problem on May 10, 2008. Male patient, weighting 163.1 lb, was diagnosed with pleural mesothelioma malignant, prophylaxis, cancer pain and was treated with ALIMTA. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, disease progression, performance status decreased, renal impairment, . ALIMTA dosage: 750 MG, OTHER. During the same period patient was treated with RANDA, FOLIAMIN, PANVITAN, CYANOCOBALAMIN, DECADRON. Patient was hospitalized. Patient recovered.

Chantix Side Effects Report #5694983-X
CHANTIX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 25, 2008. Male patient, 44 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: attention deficit/hyperactivity disorder, performance status decreased, . CHANTIX dosage: unknown. During the same period patient was treated with STRATTERA, RITALIN, REQUIP. Patient recovered.

Mylotarg Side Effects Report #5344325-4
Physician from JAPAN reported MYLOTARG problem on May 25, 2007. Male patient, weighting 163.1 lb, was diagnosed with t-cell type acute leukaemia, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, neutropenia, performance status decreased, pleurisy, pneumonia, venoocclusive liver disease, white blood cell count decreased, . MYLOTARG dosage: unknown. During the same period patient was treated with BAKTAR, ACINON, ASPARTATE CALCIUM, VITAJECT, ALFAROL, FRAGMIN. Patient was hospitalized. Patient died on 08/24/2006.

Tykerb Side Effects Report #5355601-3
TYKERB problem was reported by a Health Professional from UNITED STATES on June 11, 2007. Female patient, 83 years of age, was diagnosed with breast cancer and was treated with TYKERB. After drug was administered, patient experienced the following problems/side effects: asthenia, nausea, performance status decreased, rash, tremor, . TYKERB dosage: 1250MG PER DAY. During the same period patient was treated with AMIODARONE, LEVOTHYROXINE, GLUCOPHAGE, GLYBURIDE, AVAPRO, DEMECLOCYCLINE. Patient recovered.

Thalidomide Side Effects Report #5319946-5
Physician from UNITED KINGDOM reported THALIDOMIDE problem on Apr 25, 2007. Female patient, 69 years of age, was diagnosed with multiple myeloma and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: atelectasis, cardiopulmonary failure, performance status decreased, . THALIDOMIDE dosage: 50 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VELCADE, PREDNISONE. Patient was hospitalized. Patient died on 03/30/2007.

Quadramet Side Effects Report #5352516-1
QUADRAMET problem was reported by a Health Professional from UNITED STATES on July 04, 2006. Male patient, 66 years of age, weighting 180.8 lb, was treated with QUADRAMET. After drug was administered, patient experienced the following problems/side effects: karnofsky scale worsened, pain, performance status decreased, spinal fracture, . QUADRAMET dosage: unknown. Patient was hospitalized. Patient died on 10/01/2001.

Bevacizumab Side Effects Report #5301453-7
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Apr 12, 2007. Male patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: dehydration, oesophageal pain, performance status decreased, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with ERLOTINIB. Patient was hospitalized. Patient recovered.

Dexedrine Side Effects Report #5309683-5
DEXEDRINE problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2006. Female patient, 32 years of age, was treated with DEXEDRINE. After drug was administered, patient experienced the following problems/side effects: mental impairment, performance status decreased, somnolence, thinking abnormal, . DEXEDRINE dosage: unknown. During the same period patient was treated with PROZAC, XANAX. Patient recovered.

Cyclophosphamide Side Effects Report #5270992-X
Health Professional from ITALY reported CYCLOPHOSPHAMIDE problem on Mar 20, 2007. Female patient, 41 years of age, weighting 169.8 lb, was diagnosed with breast cancer and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, oesophagitis, performance status decreased, stomatitis, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with METHOTREXATE, CAPECITABINE. Patient was hospitalized. Patient recovered.